Malfunction of bone marrow-derived osteoclasts and the delay of bone fracture healing in diabetic mice

Bone

Volumn 47, Issue 3, 2010, Pages 617-625

  Kasahara, Toshiyuki ^a   Imai, Sinji ^a   Kojima, Hideto ^a   Katagi, Miwako ^a   Kimura, Hiroshi ^a   Chan, Lawrence ^b   Matsusue, Yoshitaka ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cell fusion; Diabetes mellitus; Fracture healing; Green fluorescent protein; Osteoclasts

Indexed keywords

CATHEPSIN K; DENDRITC CELL SPECIFIC TRANSMEMBRANE PROTEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GREEN FLUORESCENT PROTEIN; MEMBRANE PROTEIN; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MINERALIZATION; CALLUS; CELL FUNCTION; CHONDROLYSIS; CONTROLLED STUDY; DIABETES MELLITUS; FRACTURE HEALING; FRACTURE NONUNION; GENE EXPRESSION; GENE FUSION; LASER CAPTURE MICRODISSECTION; MALE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOLYSIS; RNA ISOLATION; RNA TRANSCRIPTION; STREPTOZOCIN DIABETES; TRANSGENIC MOUSE;

ANIMALS; BONE MARROW CELLS; BONE RESORPTION; CARTILAGE; DIABETES MELLITUS, EXPERIMENTAL; FRACTURE HEALING; FRACTURES, BONE; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OSTEOCLASTS;

EID: 77955843622     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2010.06.014     Document Type: Article

References (42)

1. Federation I.D. Diabetes atlas 2006, International Diabetes Federation, Brussels. Third edition.
2. Albright F. Parathyroid glands and metabolic bone disease 1948, The Williams and Wilkins Company, Baltimore.
3. Kemink S.A., Hermus A.R., Swinkels L.M., Lutterman J.A., Smals A.G. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology. J Endocrinol Invest 2000, 23:295-303.
4. Inzerillo A.M., Epstein S. Osteoporosis and diabetes mellitus. Rev Endocr Metab Disord 2004, 5:261-268.
5. Gaston M.S., Simpson A.H. Inhibition of fracture healing. J Bone Joint Surg Br 2007, 89:1553-1560.
6. Wittrant Y., Gorin Y., Woodruff K., Horn D., Abboud H.E., Mohan S., et al. High d(+)glucose concentration inhibits RANKL-induced osteoclastogenesis. Bone 2008, 42:1122-1130.
7. Hamada Y., Kitazawa S., Kitazawa R., Fujii H., Kasuga M., Fukagawa M. Histomorphometric analysis of diabetic osteopenia in streptozotocin-induced diabetic mice: a possible role of oxidative stress. Bone 2007, 40:1408-1414.
8. Valcourt U., Merle B., Gineyts E., Viguet-Carrin S., Delmas P.D., Garnero P. Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation. J Biol Chem 2007, 282:5691-5703.
9. Einhorn T.A. The cell and molecular biology of fracture healing. Clin Orthop Relat Res 1998, S7-S21.
10. Ford J.L., Robinson D.E., Scammell B.E. Endochondral ossification in fracture callus during long bone repair: the localisation of 'cavity-lining cells' within the cartilage. J Orthop Res 2004, 22:368-375.
11. Eriksen E.F., Eghbali-Fatourechi G.Z., Khosla S. Remodeling and vascular spaces in bone. J Bone Miner Res 2007, 22:1-6.
12. Rahn B.A., Gallinaro P., Baltensperger A., Perren S.M. Primary bone healing. An experimental study in the rabbit. J Bone Joint Surg Am 1971, 53:783-786.
13. Taguchi K., Ogawa R., Migita M., Hanawa H., Ito H., Orimo H. The role of bone marrow-derived cells in bone fracture repair in a green fluorescent protein chimeric mouse model. Biochem Biophys Res Commun 2005, 331:31-36.
14. Mackie E.J., Ahmed Y.A., Tatarczuch L., Chen K.S., Mirams M. Endochondral ossification: how cartilage is converted into bone in the developing skeleton. Int J Biochem Cell Biol 2008, 40:46-62.
15. Schenk R.K., Spiro D., Wiener J. Cartilage resorption in the tibial epiphyseal plate of growing rats. J Cell Biol 1967, 34:275-291.
16. Engsig M.T., Chen Q.J., Vu T.H., Pedersen A.C., Therkidsen B., Lund L.R., et al. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol 2000, 151:879-889.
17. Ishii M., Saeki Y. Osteoclast cell fusion: mechanisms and molecules. Mod Rheumatol 2008, 18:220-227.
18. Asagiri M., Takayanagi H. The molecular understanding of osteoclast differentiation. Bone 2007, 40:251-264.
19. Kim J.M., Jeong D., Kang H.K., Jung S.Y., Kang S.S., Min B.M. Osteoclast precursors display dynamic metabolic shifts toward accelerated glucose metabolism at an early stage of RANKL-stimulated osteoclast differentiation. Cell Physiol Biochem 2007, 20:935-946.
20. Terashima T., Kojima H., Fujimiya M., Matsumura K., Oi J., Hara M., et al. The fusion of bone-marrow-derived proinsulin-expressing cells with nerve cells underlies diabetic neuropathy. Proc Natl Acad Sci USA 2005, 102:12525-12530.
21. Fujimiya M., Kojima H., Ichinose M., Arai R., Kimura H., Kashiwagi A., et al. Fusion of proinsulin-producing bone marrow-derived cells with hepatocytes in diabetes. Proc Natl Acad Sci U S A 2007, 104:4030-4035.
22. Bonnarens F., Einhorn T.A. Production of a standard closed fracture in laboratory animal bone. J Orthop Res 1984, 2:97-101.
23. Parfitt A.M., Drezner M.K., Glorieux F.H., Kanis J.A., Malluche H., Meunier P.J., et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 1987, 2:595-610.
24. Morinobu M., Nakamoto T., Hino K., Tsuji K., Shen Z.J., Nakashima K., et al. The nucleocytoplasmic shuttling protein CIZ reduces adult bone mass by inhibiting bone morphogenetic protein-induced bone formation. J Exp Med 2005, 201:961-970.
25. Amano S., Hanazawa S., Kawata Y., Ohta K., Kitami H., Kitano S. An assay system utilizing devitalized bone for assessment of differentiation of osteoclast progenitors. J Bone Miner Res 1992, 7:321-328.
26. Hattersley G., Dorey E., Horton M.A., Chambers T.J. Human macrophage colony-stimulating factor inhibits bone resorption by osteoclasts disaggregated from rat bone. J Cell Physiol 1988, 137:199-203.
27. Claudino M., Garlet T.P., Cardoso C.R., de Assis G.F., Taga R., Cunha F.Q., et al. Down-regulation of expression of osteoblast and osteocyte markers in periodontal tissues associated with the spontaneous alveolar bone loss of interleukin-10 knockout mice. Eur J Oral Sci 2010, 118:19-28.
28. Cannon C.P., Lin P.P., Lewis V.O., Yasko A.W. Management of radiation-associated fractures. J Am Acad Orthop Surg 2008, 16:541-549.
29. Inaba M., Terada M., Koyama H., Yoshida O., Ishimura E., Kawagishi T., et al. Influence of high glucose on 1,25-dihydroxyvitamin D3-induced effect on human osteoblast-like MG-63 cells. J Bone Miner Res 1995, 10:1050-1056.
30. Gopalakrishnan V., Vignesh R.C., Arunakaran J., Aruldhas M.M., Srinivasan N. Effects of glucose and its modulation by insulin and estradiol on BMSC differentiation into osteoblastic lineages. Biochem Cell Biol 2006, 84:93-101.
31. Botolin S., Faugere M.C., Malluche H., Orth M., Meyer R., McCabe L.R. Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice. Endocrinology 2005, 146:3622-3631.
32. Beam H.A., Parsons J.R., Lin S.S. The effects of blood glucose control upon fracture healing in the BB Wistar rat with diabetes mellitus. J Orthop Res 2002, 20:1210-1216.
33. Katayama Y., Akatsu T., Yamamoto M., Kugai N., Nagata N. Role of nonenzymatic glycosylation of type I collagen in diabetic osteopenia. J Bone Miner Res 1996, 11:931-937.
34. Jones K.B., Maiers-Yelden K.A., Marsh J.L., Zimmerman M.B., Estin M., Saltzman C.L. Ankle fractures in patients with diabetes mellitus. J Bone Joint Surg Br 2005, 87:489-495.
35. Kayal R.A., Tsatsas D., Bauer M.A., Allen B., Al-Sebaei M.O., Kakar S., et al. Diminished bone formation during diabetic fracture healing is related to the premature resorption of cartilage associated with increased osteoclast activity. J Bone Miner Res 2007, 22:560-568.
36. McCabe L.R. Understanding the pathology and mechanisms of type I diabetic bone loss. J Cell Biochem 2007, 102:1343-1357.
37. He H., Liu R., Desta T., Leone C., Gerstenfeld L.C., Graves D.T. Diabetes causes decreased osteoclastogenesis, reduced bone formation, and enhanced apoptosis of osteoblastic cells in bacteria stimulated bone loss. Endocrinology 2004, 145:447-452.
38. Nakagawa N., Kinosaki M., Yamaguchi K., Shima N., Yasuda H., Yano K., et al. RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis. Biochem Biophys Res Commun 1998, 253:395-400.
39. Bar-Shavit Z. The osteoclast: a multinucleated, hematopoietic-origin, bone-resorbing osteoimmune cell. J Cell Biochem 2007, 102:1130-1139.
40. Yagi M., Ninomiya K., Fujita N., Suzuki T., Iwasaki R., Morita K., et al. Induction of DC-STAMP by alternative activation and downstream signaling mechanisms. J Bone Miner Res 2007, 22:992-1001.
41. Lee M.S., Kim H.S., Yeon J.T., Choi S.W., Chun C.H., Kwak H.B., et al. GM-CSF regulates fusion of mononuclear osteoclasts into bone-resorbing osteoclasts by activating the Ras/ERK pathway. J Immunol 2009, 183:3390-3399.
42. Fang Y., Shen J., Yao M., Beagley K.W., Hambly B.D., Bao S. Granulocyte-macrophage colony-stimulating factor enhances wound healing in diabetes via upregulation of proinflammatory cytokines. Br J Dermatol 2010, 162:478-486.